BRCA1 and breast cancer: The effects of downregulating BRCA1 by LSD-1 are arguably more pronounced in hereditary breast cancer with BRCA1 PV because of the additional component of genetic instability, fewer functional BRCA proteins, and an increased likelihood of loss of heterozygosity, in which the wild-type alleles of the BRCA genes are lost [106,107,108].